Quantitative RT-PCR analyses applying two different HCC cell lines (PLC, Hep3B) demonstrated that re-expression of miR-622 significantly reduced mRNA expression levels of MAPK14 and ATF2 (Figure 3D). The gene discussed is MAPK14; the disease is hepatocellular carcinoma.